^
BIOMARKER:

BAX expression

i
Other names: BAX, BCL2L4, BCL2-associated X protein
Entrez ID:
Related biomarkers:
Phase 2
Dana-Farber Cancer Institute
Completed
Last update posted :
03/29/2018
Initiation :
06/01/2002
Primary completion :
03/01/2005
Completion :
03/01/2005
BCL2 • AKT1 • BAX • PTGS2 • CD31
|
BCL2 expression • BAX expression • CD31 expression • PTGS2 expression • VEGFA expression
|
celecoxib oral
Phase N/A
Wake Forest University Health Sciences
Completed
Last update posted :
03/15/2017
Initiation :
04/01/2004
Primary completion :
02/01/2008
Completion :
02/01/2008
BCL2 • BCL2L1 • BAX
|
BAX expression
Phase N/A
Emory University
Completed
Last update posted :
12/08/2016
Initiation :
06/01/2006
Primary completion :
02/01/2016
Completion :
08/01/2016
MYC • BCL2 • MLH1 • TERT • MSH2 • APC • CDH1 • PTGS2 • TGFB1 • TGFA • BAK1 • CDKN1A
|
BAX expression
Phase 1
National Cancer Institute (NCI)
Completed
Last update posted :
04/15/2015
Initiation :
08/01/2006
Primary completion :
06/01/2012
Completion :
06/01/2012
AKT1 • BAX
|
BAX expression
|
bortezomib • Zarnestra (tipifarnib)
Phase 2/3
Fred Hutchinson Cancer Research Center
Completed
Last update posted :
11/28/2012
Initiation :
01/01/2001
Primary completion :
12/01/2004
Completion :
02/01/2005
BCL2 • IGF1 • BAX • IGFBP3
|
BAX expression
Phase 1
Sidney Kimmel Comprehensive Cancer Center
Completed
Last update posted :
05/03/2012
Initiation :
02/01/2007
Primary completion :
06/01/2009
BCL2 • MCL1 • MGMT • BCL2L1
|
BCL2 expression • MCL1 expression • BAX expression
|
temozolomide • R-(-)-gossypol (AT 101)